We demonstrated the potential of carbon nanoparticles (CNPs) as exogenous contrast agents for both thermoacoustic (TA) tomography (TAT) and photoacoustic (PA) tomography (PAT). In comparison to deionized water, the CNPs provided a four times stronger signal in TAT at 3 GHz. In comparison to blood, The CNPs provided a much stronger signal in PAT over a broad wavelength range of 450-850 nm. Specifically, the maximum signal enhancement in PAT was 9.4 times stronger in the near-infrared window of 635-670 nm. In vivo blood-vessel PA imaging was performed non-invasively on a mouse femoral area. The images, captured after the tail vein injection of CNPs, show a gradual enhancement of the optical absorption in the vessels by up to 230%. The results indicate that CNPs can be potentially used as contrast agents for TAT and PAT to monitor the intravascular or extravascular pathways in clinical applications.
INTRODUCTION
Thermoacoustic (TA) tomography (TAT) and photoacoustic (PA) tomography (PAT) are non-invasive techniques that uniquely synergize pure ultrasound and pure radio frequency (rf) and optical imaging, allowing both satisfactory spatial resolution and high soft-tissue contrast. [1] [2] The technique is based on the detection of acoustic waves from an object that absorbs pulsed or intensity-modulated electromagnetic energy (rf band in TAT and laser in PAT). The absorption can be associated with endogenous molecules, such as water/ion, hemoglobin, and melanin. For instance, due to the high concentration of hemoglobin (12 to 15 g/dl), blood inherently has a strong optical absorption which allows the visualization of blood vessels. However, the absorption of nonvascular tissues (e.g., lymph nodes) or intravascular biosignatures (e.g., integrins) is insufficient. Thus, exogenous contrast agents such as optical dyes, gold nanoparticles, copper nanoparticles, and carbon nanotubes are needed for TAT/PAT in these cases. [3] [4] [5] [6] TAT and PAT have been developed for different applications in rodent models, such as breast cancer imaging, brain structural and functional imaging, blood oxygenation and flow velocity monitoring, and tumor angiogenesis. 1, [7] [8] Although a lot of contrast agents are available for TAT and PAT, they have their disadvantages. For example, optical dyes easily cause skin staining; gold nanoparticles are high in cost and have complicated chemistries; and the toxicity of copper nanoparticles and carbon nanotubes is arguable. Therefore, new contrast agents still deserve exploration. We reveal a simple and commercially amenable synthetic methodology for creating optically active carbon nanoparticles (CNP). CNPs are derived from commercial food-grade honey. Compare to the previously explored particles (gold, copper, carbon nanotube etc.), CNPs are significantly smaller (~8 nm in diameter), enabling rapid clearance properties.
In this study, we explore the rf and optical absorbtion properties of carbon nanoparticles (CNPs) as multimodal contrast agents for both TAT and PAT. Then, we further monitor the pharmacokinetics of CNPs in blood vessels in mice in vivo using PAT. The results could be greatly beneficial for monitor the intravascular or extravascular pathways using TAT/PAT together with other structural imaging modalities.
MATERIALS AND METHODS

Synthesis of optically active carbon nanoparticles
Commercial grade honey (Great Value™ Clover Honey 1 wt%; batch composition-fructose: 38%, glucose: 31%, maltose: 7.1%, sucrose: 1.3%, higher sugars: 1.5%, water: 17.2%) is suspended with an organic macromolecular passivating agent (8wt%; PEG400), purged with argon, and heated in a domestic microwave oven for 30 min. Microwave power was set at 1200 W with an output power of 50%. The product was then purified by repeated centrifugation in water.
Thermoacoustic system
For thermoacoustic excitation, a 3.0-GHz microwave generator with pulse width of 0.6 μs and repetition rate of 10 Hz was employed. The pulses were guided toward the target through a horn antenna. The size of the antenna opening was 11 cm × 7 cm. The fluence is 0.45 mJ/cm 2 at the opening of the antenna, which is within the safety standard. The test samples were placed in a plastic tank filled with mineral oil for ultrasonic coupling. A 1-MHz spherically focused transducer with a bandwidth of 70% (V314, Panametrics, Olympus) was used to receive TA signals.
Photoacoustic system
The schematic of the system has been reported before. 9 For photoacoustic excitation, three different light sources were employed for different spectra range or imaging speed: 1) a tunable OPO laser (450-685 nm, Vibrant (HE) 355 I, OPOTEK), pulse width 5 ns, pulse repetition rate 10 Hz; 2) a tunable Ti:sapphire laser (730-850 nm, LT-2211A, LOTIS TII) pumped by a Q-switched Nd:YAG (LS-2137/2, LOTIS TII), pulse width <15 ns, pulse repetition rate 10 Hz; and 3) a dye laser (CBR-D, Sirah) pumped by a Nd:YLF laser (INNOSLAB, Edgewave), pulse width <7 ns, pulse repetition rate up to 5 kHz. The first two sources were used for the measurement of the PA spectrum of CNPs. The third source was used for fast PA imaging in vivo. The fluence is < 1 mJ/cm 2 on the sample surface. For photoacoustic detection, a focused ultrasonic transducer with 50 MHz central frequency (V214-BB-RM, Olympus NDT) was employed. The transducer surface was immersed in water for ultrasonic coupling. The optical and ultrasonic foci were configured coaxially and confocally. This system could achieve 45 μm lateral resolution, 15 μm axial resolution, and more than 3 mm penetration depth.
Animals
All animal experiments were performed in accordance with protocols approved by the Washington University Department of Comparative Medicine and the Animal Studies Committee. Athymic nude mice were obtained from Harlan and housed in the animal facility at Washington University. During the experiments, the animals were anesthetized by administration of gaseous isoflurane (2%, Butler Inc., Dublin) and aseptically prepared. 10 At (Fig. 2) . 
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CONCLUSION
In summary, we have successfully demonstrated the potential of carbon nanoparticles (CNPs) as exogenous contrast agents for both thermoacoustic tomography (TAT) and photoacoustic tomography (PAT). The CNPs provided more than 4 times signal enhancement in TAT at 3 GHz and more than 9.4 times signal enhancement in PAT in the NIR window of 635-670 nm. The results indicate that CNPs can be potentially used as contras agents for TAT and PAT together with other structural imaging modalities to monitor the intravascular or extravascular pathways in clinical applications.
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